v3.25.4
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 32,363 $ 54,486
Investment securities, available-for-sale 42,471 20,216
Restricted cash, current 497 261
Accounts receivable, net of allowances 47 926
Inventory 745 2,294
Other current assets 4,989 4,287
Total current assets 81,112 82,470
Property and equipment, net 4,280 7,061
Operating lease right-of-use assets 14,075 16,746
Restricted cash, net of current portion 1,204 1,500
Intangible assets, net 32 10,972
Other assets 2,416 2,412
Total assets 103,119 121,161
Current liabilities    
Accounts payable 1,628 1,132
Accrued liabilities 5,426 2,542
Contract liabilities 308
Derivative liability 14,581
Notes payable, current 19,212 24,248
Operating lease liabilities, current 3,481 2,682
Finance lease liabilities, current 14
Other current liabilities 388 458
Total current liabilities 30,149 45,951
Notes payable, net of current portion 8,754
Warrant liability 1,875
Operating lease liabilities, net of current portion 14,034 15,954
Finance lease liabilities, net of current portion 27
Other long-term liabilities 1,486 1,733
Total liabilities 47,571 72,392
Commitments and contingencies (Note 12)
Shareholders’ equity    
Preferred stock, par value $0.001; 25,000 shares authorized; zero and zero shares issued and outstanding as of December 31, 2025 and 2024
Common stock, par value $0.001; 510,000 shares authorized; 306,509 and 224,993 shares issued and outstanding as of December 31,  2025 and 2024, respectively 306 225
Additional paid-in capital 1,011,835 910,825
Accumulated other comprehensive income 669
Accumulated deficit (957,262) (862,281)
Total shareholders’ equity 55,548 48,769
Total liabilities and shareholders’ equity $ 103,119 $ 121,161

Source

HTML PDF
ZIP